+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Syphilis Immunoassay Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

  • PDF Icon

    Report

  • 207 Pages
  • December 2019
  • Region: Global
  • Transparency Market Research
  • ID: 4911418
Syphilis Immunoassay Diagnostics Market - Scope of the Report

The report on the global syphilis immunoassay diagnostics market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market for the forecast period of 2019 to 2027. The report provides the overall market revenue of the global syphilis immunoassay diagnostics market for the period of 2017 - 2027, with 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global syphilis immunoassay diagnostics market for the forecast period.

The report has been prepared after extensive primary and secondary research. Primary research involves bulk of the research efforts, wherein, analysts carry out interviews with key opinion leaders, industry leaders, and opinion makers. Extensive secondary research involves referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global syphilis immunoassay diagnostics market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of the top-down and bottom-up approach to study various phenomena in the global syphilis immunoassay diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global syphilis immunoassay diagnostics market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global syphilis immunoassay diagnostics market.

The report delves into the competitive landscape of the global syphilis immunoassay diagnostics market. Key players operating in the global syphilis immunoassay diagnostics market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOTs are some of the attributes of the players in the global syphilis immunoassay diagnostics market that have been profiled in this report.

Key Questions Answered in Syphilis Immunoassay Diagnostics Market Report

  • What is the sales/revenue expected to be generated by each product type across all regions during the forecast period?
  • What are the opportunities in the global syphilis immunoassay diagnostics market?
  • What are the major drivers, restraints, opportunities, and threats in the syphilis immunoassay diagnostics market?
  • Which region is likely to expand at the fastest CAGR during the forecast period?
  • Which syphilis immunoassay diagnostics and technology segments are expected to generate the highest revenue, globally, in 2027? Which segment is projected to expand at the highest CAGR during the forecast period?
  • What was the market share or position of different companies operating in the global syphilis immunoassay diagnostics market in 2018?

Global Syphilis Immunoassay Diagnostics Market - Research Objectives and Research Approach

The comprehensive report on the global syphilis immunoassay diagnostics market begins with an overview of the said market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study, technological advancement in different analyzers, syphilis disease prevalence & incident rate, number of syphilis tests done in the year 2018, cost of the test as per technology, and key mergers & acquisitions in the market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into small sections. The entire report comprises an exhaustive collection of graphs and tables appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology3. Executive Summary : Global Syphilis Immunoassay Diagnostics Market
4. Market Overview
4.1. Introduction
4.1.1. Class Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
5. Market Outlook
5.1. Technological Advancement
5.2. Key Merger & Acquisition
5.3. Top Three Players- Analysis
5.4. Number of Syphilis Diagnostic Test, by Technology (2018)
5.5. Pricing Analysis by Technology
5.6. Disease Prevalence & Incidence Rate
6. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecast, by Product, 2017-2027
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2027
6.3.1. Analyzers
6.3.2. Kits & Reagents
6.4. Global Syphilis Immunoassay Diagnostics Market Attractiveness, by Product
7. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecast, by Technology, 2017-2027
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017–2027
7.3.1. ELISA
7.3.2. CLIA
7.3.3. Others
7.4. Market Attractiveness, by Technology
8. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017–2027
8.3.1. Hospitals
8.3.2. Diagnostics Labs
8.3.3. Blood Banks
8.3.4. Others
8.4. Global Syphilis Immunoassay Diagnostics Market Attractiveness, by End-user
9. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecast, by Region, 2017-2027
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Syphilis Immunoassay Diagnostics Market Attractiveness, by Region
10. North America Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027
10.1. Introduction
10.1.1. Key Findings
10.2. North America Syphilis Immunoassay Diagnostics Market Value Forecast, by Product, 2017–2027
10.2.1. Analyzers
10.2.2. Kits & Reagents
10.3. North America Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017-2027
10.3.1. ELISA
10.3.2. CLIA
10.3.3. Others
10.4. North America Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017-2027
10.4.1. Hospitals
10.4.2. Diagnostics Labs
10.4.3. Blood Banks
10.4.4. Others
10.5. North America Syphilis Immunoassay Diagnostics Market Value Forecast, by Country, 2017-2027
10.5.1. U.S.
10.5.2. Canada
10.6. North America Syphilis Immunoassay Diagnostics Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Technology
10.6.3. By End-user
10.6.4. By Country
11. Europe Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027
11.1. Introduction
11.1.1. Key Finding
11.2. Europe Syphilis Immunoassay Diagnostics Market Value Forecast, by Product, 2017-2027
11.2.1. Analyzers
11.2.2. Kits & Reagents
11.3. Europe Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017-2027
11.3.1. ELISA
11.3.2. CLIA
11.3.3. Others
11.4. Europe Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017-2027
11.4.1. Hospitals
11.4.2. Diagnostic Labs
11.4.3. Blood Banks
11.4.4. Others
11.5. Europe Syphilis Immunoassay Diagnostics Market Value Forecast, by Country/Sub-region, 2017-2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Russia
11.5.7. Turkey
11.5.8. Eastern Europe
11.5.9. Rest of Europe
11.6. Europe Syphilis Immunoassay Diagnostics Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Technology
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027
12.1. Introduction
12.1.1. Key Finding
12.2. Asia Pacific Syphilis Immunoassay Diagnostics Market Value Forecast, by Product, 2017-2027
12.2.1. Analyzers
12.2.2. Kits & Reagents
12.3. Asia Pacific Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017-2027
12.3.1. ELISA
12.3.2. CLIA
12.3.3. Others
12.4. Asia Pacific Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017-2027
12.4.1. Hospitals
12.4.2. Diagnostic Labs
12.4.3. Blood Banks
12.4.4. Others
12.5. Asia Pacific Syphilis Immunoassay Diagnostics Market Value Forecast, by Country/Sub-region, 2017-2027
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. South Korea
12.5.6. Vietnam
12.5.7. Rest of Asia Pacific
12.6. Asia Pacific Syphilis Immunoassay Diagnostics Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Technology
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027
13.1. Introduction
13.1.1. Key Finding
13.2. Latin America Syphilis Immunoassay Diagnostics Market Value Forecast, by Product, 2017-2027
13.2.1. Analyzers
13.2.2. Kits & Reagents
13.3. Latin America Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017-2027
13.3.1. ELISA
13.3.2. CLIA
13.3.3. Others
13.4. Latin America Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017-2027
13.4.1. Hospitals
13.4.2. Diagnostic Labs
13.4.3. Blood Banks
13.4.4. Others
13.5. Latin America Syphilis Immunoassay Diagnostics Market Value Forecast by Country/Sub-region, 2017-2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Argentina
13.5.4. Rest of Latin America
13.6. Latin America Syphilis Immunoassay Diagnostics Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Technology
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027
14.1. Introduction
14.1.1. Key Finding
14.2. Middle East & Africa Syphilis Immunoassay Diagnostics Market Value Forecast, by Product, 2017-2027
14.2.1. Analyzers
14.2.2. Kits & Reagents
14.3. Middle East & Africa Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017-2027
14.3.1. ELISA
14.3.2. CLIA
14.3.3. Others
14.4. Middle East & Africa Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017-2027
14.4.1. Hospitals
14.4.2. Diagnostic Labs
14.4.3. Blood Banks
14.4.4. Others
14.5. Middle East & Africa Syphilis Immunoassay Diagnostics Market Value Forecast, by Country/Sub-region, 2017-2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Maghreb
14.5.4. Rest of Middle East & Africa
14.6. Middle East & Africa Syphilis Immunoassay Diagnostics Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Technology
14.6.3. By End-users
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis by Company (2018)
15.3. Company Profiles
15.3.1. F. Hoffmann-La Roche AG
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Company Financials
15.3.1.3. Growth Strategies
15.3.1.4. SWOT Analysis
15.3.2. Bio-Rad Laboratories, Inc.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Company Financials
15.3.2.3. Growth Strategies
15.3.2.4. SWOT Analysis
15.3.3. BD
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Company Financials
15.3.3.3. Growth Strategies
15.3.3.4. SWOT Analysis
15.3.4. Siemens Healthineers AG
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Company Financials
15.3.4.3. Growth Strategies
15.3.4.4. SWOT Analysis
15.3.5. DiaSorin S.p.A.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Company Financials
15.3.5.3. Growth Strategies
15.3.5.4. SWOT Analysis
15.3.6. Abbott
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Company Financials
15.3.6.3. Growth Strategies
15.3.6.4. SWOT Analysis
15.3.7. Ortho Clinical Diagnostics (a part of Carlyle Group)
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Company Financials
15.3.7.3. Growth Strategies
15.3.7.4. SWOT Analysis
15.3.8. Shenzhen New Industries Biomedical Engineering Co., Ltd.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Company Financials
15.3.8.3. Growth Strategies
15.3.8.4. SWOT Analysis
15.3.9. bioMérieux SA
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Company Financials
15.3.9.3. Growth Strategies
15.3.9.4. SWOT Analysis
15.3.10. Fujirebio (Miraca Group)
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Company Financials
15.3.10.3. Growth Strategies
15.3.10.4. SWOT Analysis
15.3.11. Danaher (Beckman Coulter, Inc.)
15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.12.2. Company Financials
15.3.12.3. Growth Strategies
15.3.12.4. SWOT Analysis

Companies Mentioned

A selection of companies mentioned in this report includes:

  • F. Hoffmann-La Roche AG
  • Bio-Rad Laboratories, Inc.
  • BD
  • Siemens Healthineers AG
  • DiaSorin S.p.A.
  • Abbott
  • Ortho Clinical Diagnostics (a part of Carlyle Group)
  • Shenzhen New Industries Biomedical Engineering Co. Ltd.
  • bioMérieux SA
  • Fujirebio (Miraca Group)
  • Danaher (Beckman Coulter, Inc.)